Anteris Technologies Ltd (OTCPK:AMEUF)
$ 6.5 0.4326 (7.13%) Market Cap: 130.02 Mil Enterprise Value: 124.44 Mil PE Ratio: 0 PB Ratio: 32.50 GF Score: 50/100

Anteris Technologies Ltd Annual Shareholders Meeting Transcript

May 29, 2024 / 12:00AM GMT
Release Date Price: $13.5
Wayne Paterson
Anteris Technologies Ltd - Chief Executive Officer, Managing Director, Executive Director

So good morning, everybody. Thank you for attending this morning. I'm obviously super excited to be back in Australia and Sydney as always on a lovely day. As John pointed out there, we're at the sharp end of this thing now. And what I want to talk to you today about is the very deliberate nature of how this product moves from here, through the FDA and into market. Because I get a lot of questions, more comments about what we can and can't do as a small company, from folks who maybe don't necessarily know what we can and can't do as a small company.

So today I'm going to walk through obviously the financial results from last year, but also give you a view as to what's coming this year, particularly around the FDA and those things. I'm going to start with a little video. We've compressed about four years into four minutes here. And the reason I did that is to show how this product came about, that it's not a random event. The fact that it's clinically superior and market leading is not a

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot